These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

132 related articles for article (PubMed ID: 17159357)

  • 21. Structure-based approaches to antibiotic drug discovery.
    Nicola G; Abagyan R
    Curr Protoc Microbiol; 2009 Feb; Chapter 17():Unit17.2. PubMed ID: 19235149
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The application of RAGE and GECKO in cell-based target discovery screens.
    Brunden K; Sherf B; Harrington J
    Pharmacogenomics; 2005 Jun; 6(4):383-92. PubMed ID: 16004556
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Human genome project: pharmacogenomics and drug development.
    Ganguly NK; Bano R; Seth SD
    Indian J Exp Biol; 2001 Oct; 39(10):955-61. PubMed ID: 11883519
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The 7 TM G-protein-coupled receptor target family.
    Jacoby E; Bouhelal R; Gerspacher M; Seuwen K
    ChemMedChem; 2006 Aug; 1(8):761-82. PubMed ID: 16902930
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Tumour heterogeneity and drug resistance: personalising cancer medicine through functional genomics.
    Lee AJ; Swanton C
    Biochem Pharmacol; 2012 Apr; 83(8):1013-20. PubMed ID: 22192819
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Antibacterial drug discovery--then, now and the genomics future.
    Monaghan RL; Barrett JF
    Biochem Pharmacol; 2006 Mar; 71(7):901-9. PubMed ID: 16494849
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Towards quantitative biology: integration of biological information to elucidate disease pathways and to guide drug discovery.
    Fischer HP
    Biotechnol Annu Rev; 2005; 11():1-68. PubMed ID: 16216773
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Yeast genomics and proteomics in drug discovery and target validation.
    Parsons AB; Geyer R; Hughes TR; Boone C
    Prog Cell Cycle Res; 2003; 5():159-66. PubMed ID: 14593709
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Mesopore-assisted profiling strategies in clinical proteomics for drug/target discovery.
    Savino R; Terracciano R
    Drug Discov Today; 2012 Feb; 17(3-4):143-52. PubMed ID: 22016086
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [A new approach to pharmacogenomics].
    Fujita Y
    Nihon Yakurigaku Zasshi; 2000 Sep; 116(3):149-57. PubMed ID: 11031744
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The story so far in R&D.
    Prous JR; Khurdayan VK
    Drug News Perspect; 2007; 20(1):7-15. PubMed ID: 17332897
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The future of regulatory toxicology: impact of the biotechnology revolution.
    MacGregor JT
    Toxicol Sci; 2003 Oct; 75(2):236-48. PubMed ID: 12883082
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Macromolecular versus small-molecule therapeutics: drug discovery, development and clinical considerations.
    Cho MJ; Juliano R
    Trends Biotechnol; 1996 May; 14(5):153-8. PubMed ID: 8645449
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Recent patents in the discovery of small molecule inhibitors of JAK3.
    Wilson LJ
    Expert Opin Ther Pat; 2010 May; 20(5):609-23. PubMed ID: 20402545
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Mammalian synthetic biology--from tools to therapies.
    Aubel D; Fussenegger M
    Bioessays; 2010 Apr; 32(4):332-45. PubMed ID: 20238390
    [TBL] [Abstract][Full Text] [Related]  

  • 36. High-throughput virtual screening for drug discovery in parallel.
    Toledo-Sherman LM; Chen D
    Curr Opin Drug Discov Devel; 2002 May; 5(3):414-21. PubMed ID: 12058617
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Antisense and RNAi: powerful tools in drug target discovery and validation.
    Lavery KS; King TH
    Curr Opin Drug Discov Devel; 2003 Jul; 6(4):561-9. PubMed ID: 12951819
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Structure and organization of drug-target networks: insights from genomic approaches for drug discovery.
    Janga SC; Tzakos A
    Mol Biosyst; 2009 Dec; 5(12):1536-48. PubMed ID: 19763339
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Cancer cell-based genomic and small molecule screens.
    Caldwell JS
    Adv Cancer Res; 2007; 96():145-73. PubMed ID: 17161679
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Emerging real-time technologies in molecular medicine and the evolution of integrated 'pharmacomics' approaches to personalized medicine and drug discovery.
    Milward EA; Daneshi N; Johnstone DM
    Pharmacol Ther; 2012 Dec; 136(3):295-304. PubMed ID: 22951096
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.